CCL19 and cancer: Similarly, LECs express a high level of the CCR7 ligands CCL19 and CCL21, and COX-2-induced upregulation of CCR7 in cancer cells promotes the migration of cancer cells toward LECs, enhancing lymphatic invasion118.